InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by MEIER RICHARD A, Chief Financial Officer. Director active across 2 companies, notably Biomarin Pharmaceutical INC. Aggregated, 11 reports have been published. The latest transaction was filed on 24 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
04,980 shares0
Common Stock
SEC:0001567619-22-011798:0·
€2m57,230 shares@ €27.216983.7% of flow
Common Stock
SEC:0001562180-22-004076:0·
€302,9868,500 shares@ €35.64540.0027% mcap31.5% of flow
Common Stock
SEC:0001567619-22-009496:0·
036,738 shares0
Common Stock
SEC:0001562180-22-001159:0·
036,738 shares0
Common Stock
SEC:0001562180-22-001159·
€151,3786,346 shares@ €23.854100.0% of flow
Common Stock
SEC:0001562180-21-007368·
€151,3786,346 shares@ €23.8548.1% of flow
Common Stock
SEC:0001562180-21-007368:0·
05,120 shares0
Common Stock
SEC:0001567619-21-011316·
05,120 shares0
Common Stock
SEC:0001567619-21-011316:0·
€329,24415,000 shares@ €21.9496100.0% of flow
Common Stock
SEC:0001567619-21-009351·
€329,24415,000 shares@ €21.94960.0029% mcap34.2% of flow
Common Stock
SEC:0001567619-21-009351:0·
11 of 11 declarations
About MEIER RICHARD A
Richard A. Meier is a Director and Executive Vice President at BIOMARIN PHARMACEUTICAL INC and Intersect ENT, Inc. He oversees the financial operations and strategy of the companies. Meier is responsible for managing financial resources and producing financial reports. His expertise in finance is essential for ensuring the growth and profitability of the companies.
